Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Skin Cancer and Hyperthermia and Radiotherapy - SAHARA a Two-arm, Open-label, Randomized Controlled Phase II Trial

NCT06384053 is registered in ClinicalTrials.gov with Kantonsspital Winterthur KSW as lead sponsor.

NCT NCT06384053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06384053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Skin Cancer and Hyperthermia and Radiotherapy - SAHARA a Two-arm, Open-label, Randomized Controlled Phase II Trial
Lead sponsor
Kantonsspital Winterthur KSW
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2025
Completion date
July 1, 2028
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, non-melanoma skin cancer, squamous cell carcinoma skin